Jamie Dananberg - Feb 2, 2023 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role
Chief Medical Officer
Signature
/s/ Alexander Nguyen, Attorney-in-Fact for Jamie Dananberg
Stock symbol
UBX
Transactions as of
Feb 2, 2023
Transactions value $
-$4,177
Form type
4
Date filed
2/3/2023, 03:33 PM
Previous filing
Dec 15, 2022
Next filing
Mar 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UBX Common Stock, $0.0001 par value Sale -$4.18K -863 -1.33% $4.84 64.2K Feb 2, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
F2 Includes Restricted Stock Units which vest over time measured from the grant date.